Cannabist Company

The Cannabist Company Holdings earns a Neutral rating within the Neutral band, carrying mid-level conviction at three out of five. The composite sits in the high 30s, reflecting an uneven pillar profile rather than a balanced operating setup. Regulatory is the strongest contributor in the high 40s, supported by a 50-point jurisdiction posture, an 80-point enforcement subscore, and no enforcement hits. Market follows at 40 despite the absence of an available quote. Fundamentals rank in the low 30s as contraction, losses, limited scale, and weak cash-runway scoring offset a gross-margin subscore near 50 and an operating-margin subscore in the mid-60s. Editorial contributes 30, with no newsroom or brief activity recorded in CIN newsroom coverage.

Licensed fundamentals data show year-over-year revenue contraction of roughly 30%, placing the revenue-growth subscore below 20. Gross margin was approximately 29.5%, while operating margin remained negative at about 15%. Net income registered a loss approaching $179 million, and EBITDA was negative by roughly $13 million, confirming that the stretched financial condition extends beyond accounting presentation. A cash-burn ratio near 0.90 and a cash-runway subscore of 15 reinforce funding pressure, while market capitalization of roughly $14.5 million produces a single-digit scale subscore. Primary regulatory filings show no filing date on record, leaving cadence at 25, with no regulatory events recorded across either the 90-day or 180-day periods. Institutional pricing feeds also show no available quote, limiting market validation.

The clearest rerating catalyst sits within the regulatory pillar, already the company’s strongest category. A restoration of visible, timely filing cadence would strengthen the weakest regulatory component and provide current evidence on operations, capital structure, and financial progression. That improvement would complement the clean enforcement record and stable jurisdiction posture, but it would not erase the revenue decline, negative EBITDA, operating loss, or bottom-line deficit embedded in the fundamentals score. Sustained filing activity also enables licensed fundamentals data and institutional pricing feeds to reflect fresher information, creating a firmer basis for market and editorial reassessment. The single most important signal to watch is the appearance of a current primary regulatory filing that materially lifts cadence from its present low level.